Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tyler Bussian is an analyst at Brookline Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/30/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 10/14/2024 | COCH | Buy Now | Envoy Medical | $1.36 | 561.62% | Tyler Bussian23% | → $9 | Initiates | → Buy | Get Alert |
| 07/08/2024 | CRVO | Buy Now | CervoMed | $9.63 | 554.21% | Tyler Bussian23% | → $63 | Initiates | → Buy | Get Alert |
| 04/05/2024 | IMUX | Buy Now | Immunic | $1.18 | 747.39% | Tyler Bussian23% | → $10 | Initiates | → Buy | Get Alert |
| 02/28/2024 | ANVS | Buy Now | Annovis Bio | $1.65 | 445.06% | Tyler Bussian23% | → $9 | Downgrade | Buy → Hold | Get Alert |
| 11/10/2023 | ANVS | Buy Now | Annovis Bio | $1.65 | 2019.67% | Tyler Bussian23% | → $35 | Initiates | → Buy | Get Alert |
